Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and nonmotor symptoms. Nonmotor symptoms include cognitive deficits and impairment in emotions recognition ability associated with loss of dopaminergic neurons in the substantia nigra and with alteration in frontostriatal circuits. In this review, we analyzed the studies on social cognition ability in patients with PD. We searched on PubMed and Web of Science databases and screening references of included studied and review articles for additional citations. From initial 260 articles, only 18 met search criteria. A total of 496 patients were compared with 514 health controls, through 16 different tests that assessed some subcomponents of social cognition, such as theory of mind, decision-making, and emotional face recognition. Studies on cognitive function in patients with PD have focused on executive function. Patients with PD showed impairment in social cognition from the earliest stages of disease. This ability seems to not be significantly associated with other cognitive functions.
deRijkMCLaunerLBergerK. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurology. 2000;54(11 suppl 5):S21–S23.
2.
KishSJShannakKHornykiewiczO. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. N Engl J Med. 1988;318(14):876–880.
3.
KalaitzakisMEPearceRK. The morbid anatomy of dementia in Parkinson’s disease. Acta Neuropathol. 2009;118(5):587–598.
4.
ElghEDomellöfMLinderJEdströmMStenlundHForsgrenL. Cognitive function in early Parkinson’s disease: a population-based study. Eur J Neurol. 2009;16(12):1278–1284.
5.
FoltynieTBrayneCERobbinsTWBarkerRA. The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain. 2004:127(3):550–560.
6.
DirnbergerGJahanshahiM. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol. 2013;7(2):193–224.
7.
BurgessPAldermanN. Executive dysfunction. In: GoldsteinLMcNeilJ, eds. Clinical neuropsychology: A practical guide to assessment and management for clinicians (Chapter 9). Chichester, United Kingdom: John Wiley; 2004.
8.
GodefroyOAzouviPRobertPRousselMLeGallDMeulemansT. Dysexecutive syndrome: diagnostic criteria and validation study. Ann Neurol. 2010;68(6):855–864.
9.
KawamuraMKoyamaS. Social cognitive impairment in Parkinson’s disease. J Neurol. 2007;254(4):49–53.
10.
Fuller-IglesiasHSellarsBAntonucciTC. Resilience in old age: social relations as a protective factor. Res Hum Dev. 2008;5(3):181–193.
11.
CoralloFDe ColaMCLo BuonoVLorenzoGBramantiPMarinoS. Observational study of quality of life of Parkinson’s patients and their caregivers [published online June 24, 2016]. Psychogeriatrics. 2016.
12.
KempJDesprésOSellalFDufourA. Theory of Mind in normal ageing and neurodegenerative pathologies. Ageing Res Rev. 2012;11(2):199–219.
13.
Shamay-TsoorySGHarariHAharon-PeretzJLevkovitzY. The role of the orbitofrontal cortex in affective theory of mind deficits in criminal offenders with psychopathic tendencies. Cortex. 2010;46(5):668–677.
14.
FreedmanMStussDT. Theory of Mind in Parkinson’s disease. J Neurol Sci. 2011;310(1):225–227.
15.
Shamay-TsoorySG. The neural bases for empathy. Neuroscientist. 2011;17(1):18–24.
16.
PaulusMP.Neurobiology of decision-making: quo vadis?Brain Res Cogn Brain Res. 2005;23(1):2–10.
17.
BecharaADamasioHDamasioARLeeGP. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci. 1999;19(13):5473–5481.
18.
ClarkLBecharaADamasioHAitkenMRFSahakianBJRobbinsTW. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain. 2008;131(5):1311–1322.
19.
PolettiMVergalloAUliviMSonnoliABonuccelliU. Affective theory of mind in patients with Parkinson’s disease. Psychiatry Clin Neurosci. 2013;67(4):273–276.
20.
Baron-CohenSO’RiordanMJonesRStoneVPlaistedK. A new test of social sensitivity: detection of faux pas in normal children and children with Asperger syndrome. J Autism Dev Disord. 1999;29(5):407–418.
21.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
22.
BeckATWardCMandelsonM. Beck Depression Inventory (BDI). Arch Gen Psychiatry. 1961;4(6):561–571.
23.
DuboisBSlachesvskyALitvanIPillonB. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621–1626.
24.
BoddenMEMollenhauerBTrenkwalderC. Affective and cognitive Theory of Mind in patients with Parkinson’s Disease. Parkinsonism Relat Disord. 2010;16(7):466–470.
25.
KalbeESchlegelMSackAT. Dissociating cognitive from affective theory of mind: a TMS study. Cortex. 2010;46(6):769–780.
26.
Shamay-TsoorySGAharon-PeretzJLevkovitzY. The neuroanatomical basis of affective mentalizing in schizophrenia: comparison of patients with schizophrenia and patients with localized prefrontal lesions. Schizophr Res. 2007;90(1):274–283.
27.
KalbeECalabresePKohnN. Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord. 2008;14(2):93–101.
28.
SchaafAKesslerJKesslerJGrondMFinkGR. Memo-test. Ein verbaler Gedächt nist est nach der Methode des selektiven ErinnernsWeinheim, Germany: Beltz-Test-Verlag, Weinheim;1992.
29.
SchmidtRFreidlWFazekasF. The Mattis Dementia Rating Scale Normative data from 1,001 healthy volunteers. Neurology. 1994;44(5):964–964.
CarlesimoGACaltagironeCGainottiG; the MDB Group. The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment. Eur Neurol. 1996;36(6):378–384.
32.
JenkinsonCFitzpatrickRAYPetoVIVGreenhallRHymanN. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–357.
33.
GiovagnoliARDel PesceMMascheroniSSimoncelliMLaiaconaMCapitaniE. Trial making test: normative values from 287 adult controls. Ital J Neurol Sci. 1996;17(4):305–309.
34.
McNamaraPDursoRBrownALynchA. Counterfactual cognitive deficit in persons with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2003;74(8):1065–1070.
35.
HookerCRoeseNJParkS. Impoverished counterfactual thinking is associated with schizophrenia. Psychiatry. 2000;63(4):326–335.
36.
BarbarottoRLaiaconaMFrosioRVecchioMFarinatoACapitaniE. A normative study on visual reaction times and two stroop colour-word tests. Ital J Neurol Sci. 1998;19(3):161–170.
37.
ShalliceT. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci. 1982;298(1089):199–209.
38.
PruttingCAKittchnerDM. A clinical appraisal of the pragmatic aspects of language. J Speech Hear Disord. 1987;52(2):105–119.
39.
KobayakawaMKoyamaSMimuraMKawamuraM. Decision making in Parkinson’s disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord. 2008;23(4):547–552.
40.
ZungWWRichardsCBShortMJ. Self-rating depression scale in an outpatient clinic: further validation of the SDS. Arch Gen Psychiatry. 1965;13(6):508–515.
41.
CaffarraPVezzadiniGDieciFZonatoFVenneriA. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002;22(6):443–447.
MimuraMOedaRKawamuraM. Impaired decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12(3):169–175.
45.
CohenHGagnéMHHessUPourcherE. Emotion and object processing in Parkinson’s disease. Brain Cogn. 2010;72(3):457–463.
46.
BeaupréMGHessU. Cross-cultural emotion recognition among Canadian ethnic groups. J Cross Cul Psychol. 2005;36(3):355–370.
47.
BrosseauJCohenH. The representation of semantic categories in aging. Exp Aging Res. 1996;22(4):381–391.
48.
LawrenceADGoerendtIKBrooksDJ. Impaired recognition of facial expressions of anger in Parkinson’s disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia. 2007;45(1):65–74.
49.
BentonALHamsherKDVarneyNRSpreenO. Contributions to neuropsychology assessment: a clinical manual. New York, NY: Oxford University Press1983.
50.
EkmanPFriesenWV.Pictures Offacial Affect. Palo Alto, CA: Consult—ROSS Memorial Hospital Offers a Wide range of career 111 g, P5YC1101ngt,6551976; 1976.
51.
CloningerCRPrzybeckTRSvrakicDM. The tridimensional personality questionnaire: US normative data. Psychol Rep.1991;69(3):1047–1057.
52.
GoetzCGTilleyBCShaftmanSR; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
53.
XiCZhuYMuY. Theory of mind and decision-making processes are impaired in Parkinson’s disease. Behav Brain Res. 2015;279:226–233.
54.
BrandMGrecoRSchusterA. The game of dice—a new test for the assessment of risk-taking behavior. Neurorehabil Neural Repair. 2002;16:142–143.
55.
HamiltonM. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56.
BoydJL. A validity study of the Hooper Visual Organization Test. J Consult Clin Psychol. 1981;49(1):15.
58.
NarmePMourasHRousselMDuruCKrystkowiakPGodefroyO. Emotional and cognitive social processes are impaired in Parkinson’s disease and are related to behavioral disorders. Neuropsychology. 2013;27(2):182–192.
59.
BentonALHamsherKDVarneyNRSpreenO. Judgment of Line Orientation. New York, NY: Oxford University Press; 1983.
60.
WarringtonEKJamesM. VOSP Visual Object and Space Perception Test Battery. Bury St Edmunds, England: TVTC Thames Valley Test Company; 1991.
61.
RocaMTorralvaTGleichgerrchtE. Impairments in social cognition in early medicated and unmedicated Parkinson disease. Cogn Behav Neurol. 2010;23(3):152–158.
62.
KaplanEGoodglassHWeintraubS. Boston Naming Test. Austin, TX: Pro-Ed; 2001.
63.
De RenziAVignoloLA. Token test: a sensitive test to detect receptive disturbances in aphasics. Brain. 1962;85:665–678.
64.
TsuruyaNKobayakawaMKawamuraM. Is “reading mind in the eyes” impaired in Parkinson’s disease?Parkinsonism Relat Disord. 2011;17(4):246–248.
65.
McKinlayAAlbiciniMKavanaghPS. The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson’s disease. Neuropsychiatr Dis Treat. 2012;9:1071–1076.
66.
PéronJVicenteSLerayE. Are dopaminergic pathways involved in theory of mind? A study in Parkinson’s disease. Neuropsychologia. 2009;47(2):406–414.
67.
YuRLWuRMChiuMJTaiCHLinCHHuaMS. Advanced Theory of Mind in patients at early stage of Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(1):21–24.
68.
HappéFMalhiGSCheckleyS. Acquired mind-blindness following frontal lobe surgery? A single case study of impaired ‘theory of mind’ in a patient treated with stereotactic anterior capsulotomy. Neuropsychologia. 2001;39(1):83–90.
69.
GallagherHLHappéFBrunswickNFletcherPCFrithUFrithCD. Reading the mind in cartoons and stories: an fMRI study of ‘theory of mind’ in verbal and nonverbal tasks. Neuropsychologia. 2000;38(1):11–21.
70.
NelsonHE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12(4):313–324.
71.
NarmePBonnetAMDuboisBChabyL. Understanding facial emotion perception in Parkinson’s disease: the role of configural processing. Neuropsychologia. 2011;49(12):3295–3302.
72.
DavisMH.Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol. 1983;44(1):113–126.
73.
GoldbergDPHillierVF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9(01):139–145.
74.
RosenJBBrandMPolzerCEbersbachGKalbeE. Moral decision-making and theory of mind in patients with idiopathic Parkinson’s disease. Neuropsychology. 2013;27(5):562.
75.
StarckeKPolzerCWolfOTBrandM. Does stress alter everyday moral decision-making?Psychoneuroendocrinology. 2011;36(2):210–219.
76.
AndersonRJSimpsonACChannonSSamuelMBrownRG. Social problem solving, social cognition, and mild cognitive impairment in Parkinson’s disease. Behav Sci. 2013;127(2):184.
77.
ChannonSCrawfordS. Mentalising and social problem-solving after brain injury. Neuropsychol Rehabil. 2010;20(5):739–759.
78.
D’ZurillaTJNezuAMMaydeu-OlivaresA. Social Problem-solving Inventory-revised (SPSI-R). North Tonawanda, NY: Multi-Health Systems; 2002.
79.
MioshiEDawsonKMitchellJArnoldRHodgesJR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078–1085.
80.
SprengelmeyerRYoungAWMahnK. Facial expression recognition in people with medicated and unmedicated Parkinson’s disease. Neuropsychologia. 2003;41(8):1047–1057.
81.
HoehnMMYahrMD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 1998;50(2):318.
82.
PremackDWoodruffG. “Does the chimpanzee have a theory of mind?” Behav Brain Sci. 1978;1(4):515–526.
83.
SantangeloGVitaleCTrojanoL. Neuropsychological correlates of theory of mind in patients with early Parkinson’s disease. Mov Disord. 2012;27(1):98–105.
84.
LoughSGregoryCHodgesJR. Dissociation of social cognition and executive function in frontal variant frontotemporal dementia. Neurocase. 2001;7(2):123–130.
85.
YuRLWuRM. Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies. Transl Neurodegener. 2013;2(1):1.
86.
BoddenMEDodelRKalbeE. Theory of mind in Parkinson’s disease and related basal ganglia disorders: a systematic review. Mov Disord. 2010:25(1):13–27.
87.
RossiMGerschcovichERDe AchavalD. Decision-making in Parkinson’s disease patients with and without pathological gambling. Eur J Neurol. 2010;17(1):97–102.
88.
BlairRJRMorrisJSFrithCDPerrettDIDolanRJ. Dissociable neural responses to facial expressions of sadness and anger. Brain. 1999;122(5):883–893.
89.
HornakJBramhamJRollsET. Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain. 2003;126(pt 7):1691–1712
90.
BennettMRHackerPMS. Emotion and cortical-subcortical function: conceptual developments. Progress Neurobiol. 2005;75(1):29–52.
91.
BecharaADamasioARDamasioHAndersonSW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50(1):7–15.
92.
OsbornLMSilversteinSMMattesonSWestLKaminDSchwarzkopfS. Visual organization, memory and thought disorder in schizophrenia. Biol Psychiatry. 1994;35(9):633.
